Digoxin Products Oral Use; Revocation Conditions Marketing | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

FDA-2000-N-0010

Digoxin Products Oral Use; Revocation Conditions Marketing

Documents

Comments

Description

Docket Status: OPEN

Comment Period OpensJun 26, 2002

Type	Title	Posted	Comments	Status
Notice	Prescription Drug Products; Digoxin Elixir; Extension to Obtain Marketing Approval FR Doc: 04-14796	Jun 29, 2004	--

ANGIOTENSIN

CONVERTING ENZYME

CONGESTIVE HEART FAILUR

LANOXIN

CONDITIONS FOR MARKETING

ORAL USE

DIGOXIN